Caspase-3-derived C-terminal Product of Synphilin-1 Displays Antiapoptotic Function via Modulation of the p53-dependent Cell Death Pathway

Parkinson disease is the second most frequent neurodegenerative disorder after Alzheimer disease. A subset of genetic forms of Parkinson disease has been attributed to α-synuclein, a synaptic protein with remarkable chaperone properties. Synphilin-1 is a cytoplasmic protein that has been identified...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2006-04, Vol.281 (17), p.11515-11522
Hauptverfasser: Giaime, Emilie, Sunyach, Claire, Herrant, Magali, Grosso, Sébastien, Auberger, Patrick, McLean, Pamela J., Checler, Frédéric, da Costa, Cristine Alves
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 11522
container_issue 17
container_start_page 11515
container_title The Journal of biological chemistry
container_volume 281
creator Giaime, Emilie
Sunyach, Claire
Herrant, Magali
Grosso, Sébastien
Auberger, Patrick
McLean, Pamela J.
Checler, Frédéric
da Costa, Cristine Alves
description Parkinson disease is the second most frequent neurodegenerative disorder after Alzheimer disease. A subset of genetic forms of Parkinson disease has been attributed to α-synuclein, a synaptic protein with remarkable chaperone properties. Synphilin-1 is a cytoplasmic protein that has been identified as a partner of α-synuclein (Engelender, S., Kaminsky, Z., Guo, X., Sharp, A. H., Amaravi, R. K., Kleiderlein, J. J., Margolis, R. L., Troncoso, J. C., Lanahan, A. A., Worley, P. F., Dawson, V. L., Dawson, T. M., and Ross, C. A. (1999) Nat. Gen. 22, 110–114), but its function remains totally unknown. We show here for the first time that synphilin-1 displays an antiapoptotic function in the control of cell death. We have established transient and stable transfectants overexpressing wild-type synphilin-1 in human embryonic kidney 293 cells, telecephalon-specific murine 1 neurons, and SH-SY5Y neuroblastoma cells, and we show that both cell systems display lower responsiveness to staurosporine and 6-hydroxydopamine. Thus, synphilin-1 reduces procaspase-3 hydrolysis and thereby caspase-3 activity and decreases poly(ADP-ribose) polymerase cleavage, two main indicators of apoptotic cell death. Furthermore, we establish that synphilin-1 drastically reduces p53 transcriptional activity and expression and lowers p53 promoter transactivation and mRNA levels. Interestingly, we demonstrate that synphilin-1 catabolism is enhanced by staurosporine and blocked by caspase-3 inhibitors. Accordingly, we show by transcription/translation assay that recombinant caspase-3 and, to a lesser extent, caspase-6 but not caspase-7 hydrolyze synphilin-1. Furthermore, we demonstrate that mutated synphilin-1, in which a consensus caspase-3 target sequence has been disrupted, resists proteolysis by cellular and recombinant caspases and displays drastically reduced antiapoptotic phenotype. We further show that the caspase-3-derived C-terminal fragment of synphilin-1 was probably responsible for the antiapoptotic phenotype elicited by the parent wild-type protein. Altogether, our study is the first demonstration that synphilin-1 harbors a protective function that is controlled by the C-terminal fragment generated by its proteolysis by caspase-3.
doi_str_mv 10.1074/jbc.M508619200
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00092759v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925819466532</els_id><sourcerecordid>67893964</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-774f379f85a6a4f482ed1fe32317e4e5340d490b9803e1cda3689d85ea14871e3</originalsourceid><addsrcrecordid>eNqFkUFvEzEQhVcIREPhyhF8QEgcNnjW9to-RimlSK2oVCpxsxzvbNfVZr1dO6nyF_jVOCSiJ4QPtmx97814XlG8BToHKvnn-5WbXwmqatAVpc-KGVDFSibg5_NiRmkFpa6EOilexXhP8-IaXhYnUHMtqkrPil9LG0cbsWRlg5PfYkOWZcJp7Qfbk-spNBuXSGjJzW4YO9_7oQRy5uPY210kiyF5O4YxheQdOd8MLvkwkK235Core_vnmtWpQzKKfY0RhwaHRJbY9-QMberIdd4e7e518aK1fcQ3x_O0uD3_8mN5UV5-__ptubgsnaA0lVLylkndKmFry1uuKmygRVYxkMhRME4brulKK8oQXGNZrXSjBFrgSgKy0-LTwbezvRknv7bTzgTrzcXi0uzf8ph0JYXeQmY_HthxCg8bjMmsfXS5dTtg2ERTS6WZrvl_QZDAa0lZBucH0E0hxgnbvy0ANftITY7UPEWaBe-OzpvVGpsn_JhhBj4c_-Pvukc_oVn54Dpcm0pBLmwABIiMvT9grQ3G3k0-mtubigKjuSqVtcyEOhCYp7_1OJnoPA4Om2zqkmmC_1eTvwE6qcNr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17146703</pqid></control><display><type>article</type><title>Caspase-3-derived C-terminal Product of Synphilin-1 Displays Antiapoptotic Function via Modulation of the p53-dependent Cell Death Pathway</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Giaime, Emilie ; Sunyach, Claire ; Herrant, Magali ; Grosso, Sébastien ; Auberger, Patrick ; McLean, Pamela J. ; Checler, Frédéric ; da Costa, Cristine Alves</creator><creatorcontrib>Giaime, Emilie ; Sunyach, Claire ; Herrant, Magali ; Grosso, Sébastien ; Auberger, Patrick ; McLean, Pamela J. ; Checler, Frédéric ; da Costa, Cristine Alves</creatorcontrib><description>Parkinson disease is the second most frequent neurodegenerative disorder after Alzheimer disease. A subset of genetic forms of Parkinson disease has been attributed to α-synuclein, a synaptic protein with remarkable chaperone properties. Synphilin-1 is a cytoplasmic protein that has been identified as a partner of α-synuclein (Engelender, S., Kaminsky, Z., Guo, X., Sharp, A. H., Amaravi, R. K., Kleiderlein, J. J., Margolis, R. L., Troncoso, J. C., Lanahan, A. A., Worley, P. F., Dawson, V. L., Dawson, T. M., and Ross, C. A. (1999) Nat. Gen. 22, 110–114), but its function remains totally unknown. We show here for the first time that synphilin-1 displays an antiapoptotic function in the control of cell death. We have established transient and stable transfectants overexpressing wild-type synphilin-1 in human embryonic kidney 293 cells, telecephalon-specific murine 1 neurons, and SH-SY5Y neuroblastoma cells, and we show that both cell systems display lower responsiveness to staurosporine and 6-hydroxydopamine. Thus, synphilin-1 reduces procaspase-3 hydrolysis and thereby caspase-3 activity and decreases poly(ADP-ribose) polymerase cleavage, two main indicators of apoptotic cell death. Furthermore, we establish that synphilin-1 drastically reduces p53 transcriptional activity and expression and lowers p53 promoter transactivation and mRNA levels. Interestingly, we demonstrate that synphilin-1 catabolism is enhanced by staurosporine and blocked by caspase-3 inhibitors. Accordingly, we show by transcription/translation assay that recombinant caspase-3 and, to a lesser extent, caspase-6 but not caspase-7 hydrolyze synphilin-1. Furthermore, we demonstrate that mutated synphilin-1, in which a consensus caspase-3 target sequence has been disrupted, resists proteolysis by cellular and recombinant caspases and displays drastically reduced antiapoptotic phenotype. We further show that the caspase-3-derived C-terminal fragment of synphilin-1 was probably responsible for the antiapoptotic phenotype elicited by the parent wild-type protein. Altogether, our study is the first demonstration that synphilin-1 harbors a protective function that is controlled by the C-terminal fragment generated by its proteolysis by caspase-3.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M508619200</identifier><identifier>PMID: 16495229</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adrenergic Agents - pharmacology ; Apoptosis ; Biochemistry, Molecular Biology ; Carrier Proteins - genetics ; Carrier Proteins - metabolism ; Caspase 3 ; Caspases - metabolism ; Cells, Cultured ; Enzyme Inhibitors - pharmacology ; Humans ; Kidney - cytology ; Kidney - drug effects ; Kidney - metabolism ; Life Sciences ; Nerve Tissue Proteins - genetics ; Nerve Tissue Proteins - metabolism ; Neuroblastoma - metabolism ; Neuroblastoma - pathology ; Neurons - cytology ; Neurons - drug effects ; Neurons - metabolism ; Oxidopamine - pharmacology ; Poly(ADP-ribose) Polymerases - metabolism ; Recombinant Proteins - metabolism ; Signal Transduction ; Staurosporine - pharmacology ; Transcription, Genetic ; Transcriptional Activation ; Tumor Suppressor Protein p53 - genetics ; Tumor Suppressor Protein p53 - metabolism</subject><ispartof>The Journal of biological chemistry, 2006-04, Vol.281 (17), p.11515-11522</ispartof><rights>2006 © 2006 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-774f379f85a6a4f482ed1fe32317e4e5340d490b9803e1cda3689d85ea14871e3</citedby><cites>FETCH-LOGICAL-c500t-774f379f85a6a4f482ed1fe32317e4e5340d490b9803e1cda3689d85ea14871e3</cites><orcidid>0000-0003-1462-5610</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16495229$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00092759$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Giaime, Emilie</creatorcontrib><creatorcontrib>Sunyach, Claire</creatorcontrib><creatorcontrib>Herrant, Magali</creatorcontrib><creatorcontrib>Grosso, Sébastien</creatorcontrib><creatorcontrib>Auberger, Patrick</creatorcontrib><creatorcontrib>McLean, Pamela J.</creatorcontrib><creatorcontrib>Checler, Frédéric</creatorcontrib><creatorcontrib>da Costa, Cristine Alves</creatorcontrib><title>Caspase-3-derived C-terminal Product of Synphilin-1 Displays Antiapoptotic Function via Modulation of the p53-dependent Cell Death Pathway</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Parkinson disease is the second most frequent neurodegenerative disorder after Alzheimer disease. A subset of genetic forms of Parkinson disease has been attributed to α-synuclein, a synaptic protein with remarkable chaperone properties. Synphilin-1 is a cytoplasmic protein that has been identified as a partner of α-synuclein (Engelender, S., Kaminsky, Z., Guo, X., Sharp, A. H., Amaravi, R. K., Kleiderlein, J. J., Margolis, R. L., Troncoso, J. C., Lanahan, A. A., Worley, P. F., Dawson, V. L., Dawson, T. M., and Ross, C. A. (1999) Nat. Gen. 22, 110–114), but its function remains totally unknown. We show here for the first time that synphilin-1 displays an antiapoptotic function in the control of cell death. We have established transient and stable transfectants overexpressing wild-type synphilin-1 in human embryonic kidney 293 cells, telecephalon-specific murine 1 neurons, and SH-SY5Y neuroblastoma cells, and we show that both cell systems display lower responsiveness to staurosporine and 6-hydroxydopamine. Thus, synphilin-1 reduces procaspase-3 hydrolysis and thereby caspase-3 activity and decreases poly(ADP-ribose) polymerase cleavage, two main indicators of apoptotic cell death. Furthermore, we establish that synphilin-1 drastically reduces p53 transcriptional activity and expression and lowers p53 promoter transactivation and mRNA levels. Interestingly, we demonstrate that synphilin-1 catabolism is enhanced by staurosporine and blocked by caspase-3 inhibitors. Accordingly, we show by transcription/translation assay that recombinant caspase-3 and, to a lesser extent, caspase-6 but not caspase-7 hydrolyze synphilin-1. Furthermore, we demonstrate that mutated synphilin-1, in which a consensus caspase-3 target sequence has been disrupted, resists proteolysis by cellular and recombinant caspases and displays drastically reduced antiapoptotic phenotype. We further show that the caspase-3-derived C-terminal fragment of synphilin-1 was probably responsible for the antiapoptotic phenotype elicited by the parent wild-type protein. Altogether, our study is the first demonstration that synphilin-1 harbors a protective function that is controlled by the C-terminal fragment generated by its proteolysis by caspase-3.</description><subject>Adrenergic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Biochemistry, Molecular Biology</subject><subject>Carrier Proteins - genetics</subject><subject>Carrier Proteins - metabolism</subject><subject>Caspase 3</subject><subject>Caspases - metabolism</subject><subject>Cells, Cultured</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Kidney - cytology</subject><subject>Kidney - drug effects</subject><subject>Kidney - metabolism</subject><subject>Life Sciences</subject><subject>Nerve Tissue Proteins - genetics</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Neuroblastoma - metabolism</subject><subject>Neuroblastoma - pathology</subject><subject>Neurons - cytology</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>Oxidopamine - pharmacology</subject><subject>Poly(ADP-ribose) Polymerases - metabolism</subject><subject>Recombinant Proteins - metabolism</subject><subject>Signal Transduction</subject><subject>Staurosporine - pharmacology</subject><subject>Transcription, Genetic</subject><subject>Transcriptional Activation</subject><subject>Tumor Suppressor Protein p53 - genetics</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFvEzEQhVcIREPhyhF8QEgcNnjW9to-RimlSK2oVCpxsxzvbNfVZr1dO6nyF_jVOCSiJ4QPtmx97814XlG8BToHKvnn-5WbXwmqatAVpc-KGVDFSibg5_NiRmkFpa6EOilexXhP8-IaXhYnUHMtqkrPil9LG0cbsWRlg5PfYkOWZcJp7Qfbk-spNBuXSGjJzW4YO9_7oQRy5uPY210kiyF5O4YxheQdOd8MLvkwkK235Core_vnmtWpQzKKfY0RhwaHRJbY9-QMberIdd4e7e518aK1fcQ3x_O0uD3_8mN5UV5-__ptubgsnaA0lVLylkndKmFry1uuKmygRVYxkMhRME4brulKK8oQXGNZrXSjBFrgSgKy0-LTwbezvRknv7bTzgTrzcXi0uzf8ph0JYXeQmY_HthxCg8bjMmsfXS5dTtg2ERTS6WZrvl_QZDAa0lZBucH0E0hxgnbvy0ANftITY7UPEWaBe-OzpvVGpsn_JhhBj4c_-Pvukc_oVn54Dpcm0pBLmwABIiMvT9grQ3G3k0-mtubigKjuSqVtcyEOhCYp7_1OJnoPA4Om2zqkmmC_1eTvwE6qcNr</recordid><startdate>20060428</startdate><enddate>20060428</enddate><creator>Giaime, Emilie</creator><creator>Sunyach, Claire</creator><creator>Herrant, Magali</creator><creator>Grosso, Sébastien</creator><creator>Auberger, Patrick</creator><creator>McLean, Pamela J.</creator><creator>Checler, Frédéric</creator><creator>da Costa, Cristine Alves</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7TM</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0003-1462-5610</orcidid></search><sort><creationdate>20060428</creationdate><title>Caspase-3-derived C-terminal Product of Synphilin-1 Displays Antiapoptotic Function via Modulation of the p53-dependent Cell Death Pathway</title><author>Giaime, Emilie ; Sunyach, Claire ; Herrant, Magali ; Grosso, Sébastien ; Auberger, Patrick ; McLean, Pamela J. ; Checler, Frédéric ; da Costa, Cristine Alves</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-774f379f85a6a4f482ed1fe32317e4e5340d490b9803e1cda3689d85ea14871e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adrenergic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Biochemistry, Molecular Biology</topic><topic>Carrier Proteins - genetics</topic><topic>Carrier Proteins - metabolism</topic><topic>Caspase 3</topic><topic>Caspases - metabolism</topic><topic>Cells, Cultured</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Kidney - cytology</topic><topic>Kidney - drug effects</topic><topic>Kidney - metabolism</topic><topic>Life Sciences</topic><topic>Nerve Tissue Proteins - genetics</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Neuroblastoma - metabolism</topic><topic>Neuroblastoma - pathology</topic><topic>Neurons - cytology</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>Oxidopamine - pharmacology</topic><topic>Poly(ADP-ribose) Polymerases - metabolism</topic><topic>Recombinant Proteins - metabolism</topic><topic>Signal Transduction</topic><topic>Staurosporine - pharmacology</topic><topic>Transcription, Genetic</topic><topic>Transcriptional Activation</topic><topic>Tumor Suppressor Protein p53 - genetics</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Giaime, Emilie</creatorcontrib><creatorcontrib>Sunyach, Claire</creatorcontrib><creatorcontrib>Herrant, Magali</creatorcontrib><creatorcontrib>Grosso, Sébastien</creatorcontrib><creatorcontrib>Auberger, Patrick</creatorcontrib><creatorcontrib>McLean, Pamela J.</creatorcontrib><creatorcontrib>Checler, Frédéric</creatorcontrib><creatorcontrib>da Costa, Cristine Alves</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Giaime, Emilie</au><au>Sunyach, Claire</au><au>Herrant, Magali</au><au>Grosso, Sébastien</au><au>Auberger, Patrick</au><au>McLean, Pamela J.</au><au>Checler, Frédéric</au><au>da Costa, Cristine Alves</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Caspase-3-derived C-terminal Product of Synphilin-1 Displays Antiapoptotic Function via Modulation of the p53-dependent Cell Death Pathway</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2006-04-28</date><risdate>2006</risdate><volume>281</volume><issue>17</issue><spage>11515</spage><epage>11522</epage><pages>11515-11522</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Parkinson disease is the second most frequent neurodegenerative disorder after Alzheimer disease. A subset of genetic forms of Parkinson disease has been attributed to α-synuclein, a synaptic protein with remarkable chaperone properties. Synphilin-1 is a cytoplasmic protein that has been identified as a partner of α-synuclein (Engelender, S., Kaminsky, Z., Guo, X., Sharp, A. H., Amaravi, R. K., Kleiderlein, J. J., Margolis, R. L., Troncoso, J. C., Lanahan, A. A., Worley, P. F., Dawson, V. L., Dawson, T. M., and Ross, C. A. (1999) Nat. Gen. 22, 110–114), but its function remains totally unknown. We show here for the first time that synphilin-1 displays an antiapoptotic function in the control of cell death. We have established transient and stable transfectants overexpressing wild-type synphilin-1 in human embryonic kidney 293 cells, telecephalon-specific murine 1 neurons, and SH-SY5Y neuroblastoma cells, and we show that both cell systems display lower responsiveness to staurosporine and 6-hydroxydopamine. Thus, synphilin-1 reduces procaspase-3 hydrolysis and thereby caspase-3 activity and decreases poly(ADP-ribose) polymerase cleavage, two main indicators of apoptotic cell death. Furthermore, we establish that synphilin-1 drastically reduces p53 transcriptional activity and expression and lowers p53 promoter transactivation and mRNA levels. Interestingly, we demonstrate that synphilin-1 catabolism is enhanced by staurosporine and blocked by caspase-3 inhibitors. Accordingly, we show by transcription/translation assay that recombinant caspase-3 and, to a lesser extent, caspase-6 but not caspase-7 hydrolyze synphilin-1. Furthermore, we demonstrate that mutated synphilin-1, in which a consensus caspase-3 target sequence has been disrupted, resists proteolysis by cellular and recombinant caspases and displays drastically reduced antiapoptotic phenotype. We further show that the caspase-3-derived C-terminal fragment of synphilin-1 was probably responsible for the antiapoptotic phenotype elicited by the parent wild-type protein. Altogether, our study is the first demonstration that synphilin-1 harbors a protective function that is controlled by the C-terminal fragment generated by its proteolysis by caspase-3.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>16495229</pmid><doi>10.1074/jbc.M508619200</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-1462-5610</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 2006-04, Vol.281 (17), p.11515-11522
issn 0021-9258
1083-351X
language eng
recordid cdi_hal_primary_oai_HAL_hal_00092759v1
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Adrenergic Agents - pharmacology
Apoptosis
Biochemistry, Molecular Biology
Carrier Proteins - genetics
Carrier Proteins - metabolism
Caspase 3
Caspases - metabolism
Cells, Cultured
Enzyme Inhibitors - pharmacology
Humans
Kidney - cytology
Kidney - drug effects
Kidney - metabolism
Life Sciences
Nerve Tissue Proteins - genetics
Nerve Tissue Proteins - metabolism
Neuroblastoma - metabolism
Neuroblastoma - pathology
Neurons - cytology
Neurons - drug effects
Neurons - metabolism
Oxidopamine - pharmacology
Poly(ADP-ribose) Polymerases - metabolism
Recombinant Proteins - metabolism
Signal Transduction
Staurosporine - pharmacology
Transcription, Genetic
Transcriptional Activation
Tumor Suppressor Protein p53 - genetics
Tumor Suppressor Protein p53 - metabolism
title Caspase-3-derived C-terminal Product of Synphilin-1 Displays Antiapoptotic Function via Modulation of the p53-dependent Cell Death Pathway
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T19%3A34%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Caspase-3-derived%20C-terminal%20Product%20of%20Synphilin-1%20Displays%20Antiapoptotic%20Function%20via%20Modulation%20of%20the%20p53-dependent%20Cell%20Death%20Pathway&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Giaime,%20Emilie&rft.date=2006-04-28&rft.volume=281&rft.issue=17&rft.spage=11515&rft.epage=11522&rft.pages=11515-11522&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M508619200&rft_dat=%3Cproquest_hal_p%3E67893964%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17146703&rft_id=info:pmid/16495229&rft_els_id=S0021925819466532&rfr_iscdi=true